Premier Asset Management LLC Biogen Inc. Transaction History

Premier Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $9.36 Million - $12 Million	-41,814 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $708,040 - $923,363	2,502 Added 6.36%	41,814 $11.8 Million
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $2.43 Million - $3.89 Million	-9,390 Reduced 19.28%	39,312 $13.6 Million
Q1 2021 May 12, 2021	BUY	$242.95 - $284.63 $5.12 Million - $6 Million	21,067 Added 76.23%	48,702 $13.6 Million
Q4 2020 Feb 16, 2021	BUY	$236.26 - $355.63 $6.53 Million - $9.83 Million	27,635 New	27,635 $6.77 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $23B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Premier Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Premier Asset Management LLC with notifications on news.